ArticleNature communications2021
Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.
Sushila A Toulmin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this papercites it